UBS Group’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.14M Sell
1,190,647
-247,769
-17% -$654K ﹤0.01% 3446
2025
Q1
$4.33M Sell
1,438,416
-149,273
-9% -$449K ﹤0.01% 3075
2024
Q4
$4.06M Buy
1,587,689
+1,181,256
+291% +$3.02M ﹤0.01% 3170
2024
Q3
$1.51M Sell
406,433
-51,822
-11% -$193K ﹤0.01% 3253
2024
Q2
$2.9M Sell
458,255
-467,234
-50% -$2.95M ﹤0.01% 2536
2024
Q1
$4.97M Buy
925,489
+882,777
+2,067% +$4.74M ﹤0.01% 2198
2023
Q4
$214K Buy
42,712
+2,930
+7% +$14.7K ﹤0.01% 4563
2023
Q3
$67.2K Buy
39,782
+70
+0.2% +$118 ﹤0.01% 4974
2023
Q2
$110K Sell
39,712
-74,666
-65% -$208K ﹤0.01% 4880
2023
Q1
$208K Sell
114,378
-254,225
-69% -$463K ﹤0.01% 4319
2022
Q4
$1.87M Buy
368,603
+252,685
+218% +$1.28M ﹤0.01% 2613
2022
Q3
$576K Buy
115,918
+65,845
+131% +$327K ﹤0.01% 3247
2022
Q2
$186K Sell
50,073
-122,957
-71% -$457K ﹤0.01% 4008
2022
Q1
$971K Sell
173,030
-181,957
-51% -$1.02M ﹤0.01% 3254
2021
Q4
$2.16M Buy
354,987
+76,288
+27% +$464K ﹤0.01% 2812
2021
Q3
$2.71M Buy
278,699
+251,520
+925% +$2.45M ﹤0.01% 2524
2021
Q2
$388K Sell
27,179
-28,835
-51% -$412K ﹤0.01% 3914
2021
Q1
$1.33M Buy
56,014
+50,858
+986% +$1.21M ﹤0.01% 3097
2020
Q4
$69K Sell
5,156
-5,259
-50% -$70.4K ﹤0.01% 4939
2020
Q3
$72K Sell
10,415
-5,297
-34% -$36.6K ﹤0.01% 4561
2020
Q2
$193K Buy
15,712
+10,162
+183% +$125K ﹤0.01% 4023
2020
Q1
$16K Sell
5,550
-4,251
-43% -$12.3K ﹤0.01% 5724
2019
Q4
$37K Sell
9,801
-4,253
-30% -$16.1K ﹤0.01% 5471
2019
Q3
$17K Buy
14,054
+6,633
+89% +$8.02K ﹤0.01% 5866
2019
Q2
$8K Sell
7,421
-4,814
-39% -$5.19K ﹤0.01% 6307
2019
Q1
$19K Sell
12,235
-11,769
-49% -$18.3K ﹤0.01% 5513
2018
Q4
$28K Buy
24,004
+17,004
+243% +$19.8K ﹤0.01% 5616
2018
Q3
$26K Sell
7,000
-41,523
-86% -$154K ﹤0.01% 5724
2018
Q2
$149K Buy
48,523
+41,523
+593% +$128K ﹤0.01% 4289
2018
Q1
$27K Sell
7,000
-5,564
-44% -$21.5K ﹤0.01% 5321
2017
Q4
$56K Buy
12,564
+1,187
+10% +$5.29K ﹤0.01% 4804
2017
Q3
$62K Buy
11,377
+2,138
+23% +$11.7K ﹤0.01% 4760
2017
Q2
$70K Buy
9,239
+1,689
+22% +$12.8K ﹤0.01% 4514
2017
Q1
$27K Buy
7,550
+5,050
+202% +$18.1K ﹤0.01% 5027
2016
Q4
$14K Sell
2,500
-370
-13% -$2.07K ﹤0.01% 5767
2016
Q3
$23K Buy
2,870
+670
+30% +$5.37K ﹤0.01% 5298
2016
Q2
$13K Sell
2,200
-700
-24% -$4.14K ﹤0.01% 5732
2016
Q1
$24K Buy
2,900
+850
+41% +$7.03K ﹤0.01% 5242
2015
Q4
$36K Buy
2,050
+50
+3% +$878 ﹤0.01% 5031
2015
Q3
$23K Buy
+2,000
New +$23K ﹤0.01% 5344